Gehe bid referred to UK
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.MAGNUS GRIMOND
The European Commission yesterday referred scrutiny of the pounds 650m bid by Gehe of Germany for Lloyds Chemists back to the UK authorities. The bid now looks certain to be sent before the Monopolies and Mergers Commission, which is already looking at an earlier offer from UniChem, a rival British chemists chain.
In a statement, Karel van Miert, the commissioner in charge of competition policy, said Gehe-Lloyds and UniChem would have over two-thirds of the wholesale market to independent chemists following a merger and the market share would be "significantly higher" in certain regions. They would be the only two wholesalers operating in the whole of the UK and supplying a full range of pharmaceutical products.
"Based on the information currently available, regional wholesalers would appear unable to provide a sufficient competitive counterweight to the duopoly pair composed of Gehe-Lloyds and UniChem." The Commission said the present concentration threatened to create a dominant position in the wholesale market. On top of that, it had identified a small number of areas where local pharmacies owned by Gehe in the UK would appear to have a monopoly and with increased vertical integration there was a danger of a dominant position in retailing also being created.
The Commission noted that referral would have the advantage of allowing both bids to be scrutinised by the same authority.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments